Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Cash from Investing Activities came in at -$13.1 million in Q1 2026, down 203.73% year-on-year from $12.6 million in Q1 2025, and up 22.01% on a QoQ basis from -$16.8 million in Q4 2025.

Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has 17 years of Cash from Investing Activities data on file, last reported at -$13.1 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 203.73% year-over-year to -$13.1 million in Q1 2026; TTM through Mar 2026 was -$73.7 million, a 63.51% increase from a year earlier, with the FY2025 full-year figure at -$64.9 million, up 67.55% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$13.1 million, up from -$16.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for LMAT reached as high as -$402000.0 in Q4 2022 and fell as low as -$173.9 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged -$18.4 million across 5 years, with a median of -$9.6 million in 2023.
  • Across the five-year window, Cash from Investing Activities soared 94.45% in 2022 and tumbled 7590.93% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$402000.0 in 2022, then sank by 462.44% to -$2.3 million in 2023, then tumbled by 7590.93% to -$173.9 million in 2024, then soared by 90.32% to -$16.8 million in 2025, then grew by 22.01% to -$13.1 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$13.1 million in Q1 2026, -$16.8 million in Q4 2025, and -$27.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -139.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn -218.00 Mn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn -43.20 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn -131.58 Mn
10 Lemaitre Vascular 2.25 Bn 1.88 Bn 48.40 Mn -13.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.12 Mn
Mar 31, 2026 -13.12 Mn
Dec 31, 2025 -16.83 Mn
Dec 31, 2025 -16.83 Mn
Sep 30, 2025 -27.45 Mn
Sep 30, 2025 -27.45 Mn
Jun 30, 2025 -16.35 Mn
Jun 30, 2025 -16.35 Mn
Mar 31, 2025 -4.32 Mn
Mar 31, 2025 -4.32 Mn
Dec 31, 2024 -173.89 Mn
Dec 31, 2024 -173.89 Mn
Sep 30, 2024 -12.86 Mn
Sep 30, 2024 -12.86 Mn
Jun 30, 2024 -11.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -2.36 Mn
Mar 31, 2024 -2.36 Mn
Dec 31, 2023 -2.26 Mn
Dec 31, 2023 -2.26 Mn